CRTC2 and cardiovascular disorder: Hence, it remains to be determined the mechanistic basis for INHB/activin-TORC2-mediated control of cardiac aging and longevity, which will eventually help the development of therapeutic interventions targeting INHB/activin and TORC2 for the treatment of age-related cardiovascular diseases.